Overview: Here are the allegations against the SSI directors
Kammeradvokaten, legal counsel to the Danish government, accuses CEO of Danish organization Statens Serum Institut, Mads Melbye, and EVP of research Peter Lawætz Andersen of "gross breach of the rules about disqualification" as well as several other issues.
BY KEVIN GRØNNEMANN, TRANSLATED BY IDA JACOBSEN
Mads Melbye and Peter Lawætz Andersen, president and CEO and EVP of research, respectively, at Statens Serum Institut (Denmark's Serum Institute), SSI, are being accused of gross violations of the rules concerning disqualification. Meanwhile, Melbye is also accused of breaching of the Scientific Ethical Committees Act.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
